Plunkett Research Online: Intersect ENT Inc

INTERSECT ENT INC (XENT:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Intersect ENT, Inc. is a commercial stage drug-device company committed to improving the quality of life for patients with ear, nose and throat conditions. The firm has developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. Th.....



Intersect ENT Inc
Ticker: XENT
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 641-2100
Fax:
Address: 1555 Adams Drive
Menlo Park, CA 94025 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Surgical and Medical Instrument Manufacturing
ContactsDescription
Lisa EarnhardtCEO/Director/President
Jeryl HillemanCFO/Chief Accounting Officer
See More
Intersect ENT, Inc. is a commercial stage drug-device company committed to improving the quality of life for patients with ear, nose and throat conditions. The firm has developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. Th.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
PROPEL
PROPEL mini
PROPEL Contour
RESOLVE
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: